Marasco Dominic 4

What Happened Dominic Marasco, President of MannKind's Endocrine Business Unit, had 3,623 shares disposed/withheld on July 15, 2026 to satisfy tax withholding related to the vesting of previously reported restricted stock units. The shares were valued at $4.09 each, for a total of approximately $14,818. This was a tax-withholding disposal (routine), not an open-market sell intended as a directional trade.

Key Details

• Transaction date: July 15, 2026; filing date: July 17, 2026 (no late filing flag indicated).
• Disposal: 3,623 shares withheld/disposed at $4.09 per share — total about $14,818.
• Shares owned after the transaction: not provided in the supplied data (check the full Form 4 for post-transaction beneficial ownership).
• Footnotes:
  • F1: Withholding/delivery of securities to satisfy tax liabilities upon vesting of previously reported restricted stock units (per Rule 16b-3).
  • F2: Notes inclusion of 2,775 shares acquired under the issuer’s Employee Stock Purchase Plan on June 30, 2026.
• Transaction code: F (payment of exercise price or tax liability via delivery/withholding of shares).

Context This is a routine tax-withholding event tied to RSU vesting — common for insiders receiving equity compensation and generally not a signal of insider market sentiment. For precise post-transaction holdings or related prior grants/vests, review the full Form 4 filing (Accession 0001193125-26-308137).